{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-055110","form_type":"8-K","ticker":"AIFF","cik":"0000803578","company_name":"FIREFLY NEUROSCIENCE, INC.","filed_at":"2026-05-12T20:30:16+00:00","discovered_at":"2026-05-12T20:32:00.302255+00:00","generated_at":"2026-05-12T20:39:27.136619+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Firefly Neuroscience enters $1M private placement; units include common stock and warrants","bullets":["Up to 666,667 units at $1.50/unit, aggregate gross proceeds up to $1,000,000.","Each unit: 1 share common stock, 1 5-yr warrant at $1.88 exercise, 1 5-yr warrant at $2.50 exercise.","Warrants not exercisable until shareholder approval obtained; company must seek approval within 90 days.","Closing conditional on effective registration statement (due May 21, 2026) and shareholder approval.","Investor can terminate if common stock closing price below $1.50 on day of approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-055110","json":"https://secwatch.observer/filing/0001213900-26-055110.json","markdown":"https://secwatch.observer/filing/0001213900-26-055110.md","text":"https://secwatch.observer/filing/0001213900-26-055110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/803578/000121390026055110/0001213900-26-055110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/803578/000121390026055110/ea0289806-8k_firefly.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T20:39:27.136619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"942556787e2b8c5aa502b9f26efcf9422c4713b4","claim":"FIREFLY NEUROSCIENCE, INC. entered into Purchase Agreement with an accredited investor valued at aggregate gross proceeds of up to $1,000,000 (effective 2026-05-06).","evidence_excerpt":"On May 6, 2026, Firefly Neuroscience, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor up to 666,667 units (each a “Unit” and, collectively, the “Units”), at a purchase price of $1.50 per Unit, for aggregate gross proceeds of up to $1,000,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/803578/000121390026055110/0001213900-26-055110-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an accredited investor"},{"label":"Value","value":"aggregate gross proceeds of up to $1,000,000"},{"label":"Effective","value":"2026-05-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}